0

Asia –Pacific Oncology Molecular Diagnostics Market is Expected to Reach $1,241.00 Million by 2031 | 7.3% CAGR

 
2022
Asia –Pacific Oncology Molecular Diagnostics Market

Report Code : A06287

quote owing to increase in prevalence of individual suffering from different type of cancer, rise in geriatric population and rise in awareness of among the population concerning the benefits of early diagnosis across the world are the key factors anticipated to foster the growth of Asia-Pacific oncology molecular diagnostics market during the forecast period quote

Onkar Sumant
Manager, Healthcare at Allied Market Research

Get 20% Free Customization In This Report
Follow us on Social Media:       
 

According to a new report published by Allied Market Research, titled, Asia-Pacific Oncology Molecular Diagnostics Market By application, by type & end user, Opportunity Analysis and Industry Forecast, 2022–2031. The Asia-Pacific oncology molecular diagnostics market was valued at $610.17 million in 2021, and is projected to reach $1,241.00 million by 2031, registering a CAGR of 7.3% from 2022 to 2031.

Molecular diagnostics is a group of procedures applied to analyze biological markers at the molecular level such as genome and proteome in an individual's genetic code. The technique is employed by the flourishing healthcare sector to diagnose and monitor complex ailments, detect various diseases such as cancer, and most importantly decide best personalized medicines, and therapies for individual patients.

Key factors that drive growth of the market include rise in prevalence of cancer, increase in awareness and acceptance of personalized medicines, and growth in biomarker identification. However, lack of skilled professionals and stringent regulatory requirements for approval of new molecular diagnostic techniques restrain the market growth. In addition, advancements in genomics & proteomics provide opportunities for the Asia-Pacific oncology molecular diagnostics market growth.

The market is segmented on the basis of application, type, end user, and country. By application, it is segmented into colorectal cancer, hematological cancer breast cancer, lung cancer, and others. By type, it is divided into polymerase chain reaction (PCR), next-generation sequencing, fluorescence in- situ hybridization (FISH), next generation sequencing (NGS), spectrometry, and others. By end user, it is divided into hospitals, reference laboratories, and others. Country wise, the market is analyzed across Thailand, Vietnam, Singapore, Malaysia, Australia, Indonesia, the Philippines, and rest of Asia-Pacific.

By application, the lung cancer segment dominated the market in 2021, owing to increase in prevalence of lung cancer and rise in number of active smokers across the region.

By type, the polymerase chain reaction (PCR) segment dominated the market in 2021, owing to increase in adoption of PCR as it offers various advantages such as it is less time-consuming, requires low concentration of sample for test, and is easy to handle for cancer diagnosis.

By end user, the hospitals segment dominated the market in 2021, owing to increase in number of patient visits to hospitals for screening and identification of cancer.

Country wise, rest of Asia-Pacific dominated the market in 2020, owing to increase in adoption and acceptance of personalized medicine, upgradation of healthcare infrastructure, and higher investments for R&D. Furthermore, increase in prevalence of cancer in this region is expected to boost the Asia-Pacific oncology molecular diagnostics market during the forecast period.

The key players profiled in this report include Abbott Laboratories, BioMerieux S.A, Amoy Diagnostic Co Ltd, F-Hoffmann-LA Roche Ltd, Siemens Healthineers, Danaher Corporation, Diasorin SP, Thermo Fisher Scientific, Inc, Agilent Technologies Inc, Sysmex Corporation, Qiagen N.V., and Illumina Inc.

Key Findings Of The Study

  • By application, the other cancer segment was the highest contributor to the Asia-Pacific oncology molecular diagnostics market in 2021.
  • By type, the polymerase chain reaction (PCR) segment was the highest contributor to the market in 2021.
  • By end user, the hospital segment dominated the market in 2021, and is expected to continue this trend during the forecast period.
  • By country, rest of Asia-pacific garnered the largest revenue share in 2021, whereas Indonesia is anticipated to grow at the CAGR of 6.7% during the forecast period.

Need More Information

pr-det-talk Talk to David (Europe)

pr-det-talk Talk to Sona Padman (Americas)

5933 NE Win Sivers Drive #205,
Portland, OR 97220 United States

pr-det-phone Toll Free: +1-800-792-5285

pr-det-phone UK: +44-845-528-1300

pr-det-phone Hong Kong: +852-301-84916

pr-det-phone India (Pune): +91 2066346060

pr-det-phone Fax: +1(855) 550-5975

pr-det-phone help@alliedmarketresearch.com

 

For Media Inquiries, Please Contact

Allied Market Research
Contact Toll Free: +1-800-792-5285
Drop us an email at
media@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Free Sample
 
 

First time buyer?
Check offers and discount on this report
To get this report

Click Here
 
 

quote Asia–Pacific Oncology Molecular Diagnostics Market By Application (Colorectal Cancer, Hematological Cancer, Breast Cancer, Lung Cancer, and Others), Type (Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), Fluorescence In-situ Hybridization (FISH), Spectrometry, and Others), and End User (Hospitals, Reference Laboratories, and Others) - Global Opportunities and Industry Forecasts, 2022-2031 quote

View Report
 
 

Avenue: Entire Library membership of Allied Market Research Reports at your disposal

  • Avenue is an innovative subscription-based online report database.
  • Avail an online access to the entire library of syndicated reports on more than 2,000 niche industries and company profiles on more than 12,000 firms across 11 domains.
  • A cost-effective model tailored for entrepreneurs, investors, and students & researchers at universities.
  • Request customizations, suggest new reports, and avail analyst support as per your requirements.
  • Get an access to the library of reports at any time from any device and anywhere.

 
 

WHY ALLIED MARKET RESEARCH?

INFLALLIBLE METHODOLOGY

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

ANALYST SUPPORT

For complete satisfaction

CUSTOMIZATION

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 

Featured Readings

 
rep-img

Published Date Feb 2024

HIV Injection Market

Download Sample

Buy Full Version
"Asia –Pacific Oncology Molecular Diagnostics Market"
Purchase Enquiry

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of the scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save the time of readers